Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat ...

RIDE-001 was developed using Trained Therapeutix’s proprietary ApoA1-based nanomedicines platform to target the bone marrow where it activates the intracellular pattern recognition receptor NOD2. This ...

Researchers at Chiba University have developed a new nasal therapeutic vaccine as a non-invasive treatment option. In animal ...

Now, researchers from Chiba University, Japan, have developed a therapeutic HPV vaccine that can be administered through the ...

A research team from Trinity College Dublin has unveiled a new approach to vaccination that could redefine how we protect ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

PRNewswire/ -- iLeukon Therapeutics, Inc., a San Diego-based clinical-stage biotechnology company developing next-generation mRNA-based immunotherapies, announced new clinical results from the ongoing ...

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily ...

A research paper just published in Science China Life Sciences reports that the fungal virulence factor oxalic acid (OA) ...